Data as of Oct 21
| +14.88 / +4.07%|
The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 386.00, with a high estimate of 436.00 and a low estimate of 305.00. The median estimate represents a +1.31% increase from the last price of 381.01.
The current consensus among 22 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.